Dr. Rich brings over 15 years of expertise as a pharmacometrician, with a diverse background spanning biostatistics, mathematics, and computer science. Throughout his career, he has held pivotal scientific and leadership positions at esteemed consultancies such as Certara and Pumas AI, where he has made significant contributions to advancing the field of pharmacometrics.

Driven by a passion for scientific and technical innovation, Dr. Rich is committed to pushing the boundaries of what pharmacometrics can achieve. He thrives on cross-disciplinary collaboration and leverages his multidisciplinary background to tackle complex challenges in drug development. At the heart of Dr. Rich’s work is a steadfast commitment to bringing safe and effective therapies to patients in a timely and cost-effective manner. With a data-driven mindset, he utilizes statistical methodologies, modeling techniques, and simulation tools to optimize risk-benefit considerations from a patient-centric perspective.

Dr. Rich’s scholarly contributions include 37 publications, posters, and abstracts, reflecting his dedication to advancing the scientific discourse in pharmacometrics. He holds a Ph.D. in Biostatistics from McGill University, where he also completed a postdoctoral fellowship at the McGill University Health Centre. Additionally, he holds an M.Sc. in Bioinformatics from Freie Universität Berlin and a B.Sc. in Mathematics and Computer Science from McGill University. Through his expertise and collaborative approach, Dr. Rich continues to play a pivotal role in shaping the future of pharmacometrics and driving innovation in drug development.